Travel characteristics and yellow fever vaccine usage among US global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 5, 2013, Pages 954-961

  Jentes, Emily S ^a   Han, Pauline ^a   Gershman, Mark D ^a   Rao, Sowmya R ^b,c   LaRocque, Regina C ^d   Staples, J Erin ^e   Ryan, Edward T ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NIGERIA; PRESCHOOL CHILD; RISK BENEFIT ANALYSIS; SCHOOL CHILD; TRAVEL; UNITED STATES; VACCINATION; VIRUS TRANSMISSION; YELLOW FEVER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FRIENDS; HUMANS; INFANT; MALE; MIDDLE AGED; NIGERIA; PATIENT ACCEPTANCE OF HEALTH CARE; RISK ASSESSMENT; TRAVEL; TRAVEL MEDICINE; VACCINATION; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS; YOUNG ADULT;

YELLOW FEVER VIRUS;

EID: 84877119007     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0463     Document Type: Article

References (29)

1. Monath TP, Gershman M, Staples JE, Barrett ADT, 2012. Yellow fever vaccine. Plotkin SA, Orenstein W, Offit PA, eds. Vaccines. Philadelphia, PA: WB Saunders, 870-968.
2. Staples JE, Gershman M, Fischer M, 2010. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59: 1-27.
3. Gubler DJ, 2002. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33: 330-342. (Pubitemid 35299553)
4. WHO, 2008. Outbreak news. Yellow fever, Paraguay. Wkly Epidemiol Rec 83: 105.
5. WHO, 2011. Outbreak news. Yellow fever, Uganda. Wkly Epidemiol Rec 86: 37-38.
6. WHO, 2012. Yellow fever in Cameroon. Communicable Disease Surveillance and Response (CSR). Available at: http://www.who.int/csr/don/2012-02-03/en/ index.html. Accessed March 13, 2012.
7. UNWTO, 2011. UNWTO Tourism Highlights, 2011 Edition. Available at: http://mkt.unwto.org/sites/all/files/docpdf/unwtohighlights11enlr-1.pdf. Accessed December 28, 2012.
8. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077-6082.
9. Seligman SJ, 2011. Yellow fever virus vaccine-associated deaths in young women. Emerg Infect Dis 17: 1891-1893.
10. LaRocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS, Knouse M, Cahill J, Hagmann S, Vinetz J, Connor BA, Goad J, Oladele A, Alvarez S, Stauffer W, Walker P, Kozarsky P, Franco-Paredes C, Dismukes R, Rosen J, Hynes NA, Jacquerioz F, McLellan S, Hale D, Sofarelli T, Schoenfeld D, Marano N, Brunette G, Jentes ES, Yanni E, Sotir MJ, Ryan ET; the Global TravEpiNet Consortium, 2011. Demographics, travel destinations, and pre-travel health care among U.S. international travelers in Global TravEpiNet. Clin Infect Dis 54: 455-462.
11. Centers for Disease Control and Prevention, 2011. Health Information for International Travel, 2012 . Atlanta, GA: US Department of Health and Human Services, Public Health Service.
12. Jentes ES, Poumerol G, Gershman MD, Hill DR, Lemarchand J, Lewis RF, Staples JE, Tomori O, Wilder-Smith A, Monath TP, 2011. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis 11: 622-632.
13. WHO, 2011. International Travel and Health. Geneva: World Health Organization.
14. Gershman M, Schroeder B, Jentes ES, Marano N, 2009. Yellow fever vaccine requirements and recommendations, by country. Brunette GW, ed. CDC Health Information for International Travel 2010. Atlanta, GA: US Public Health Service.
15. Anonymous, 2009. World Development Report 2009: Reshaping Economic Geography. Available at: http://siteresources.worldbank.org/INTRANETTRADE/ Resources/Internal-Training/WDR-2009-Reshaping-Economic-Georgraphy.pdf. Accessed January 7, 2013.
16. Morel JG, Bokossa MC, Neerchal NK, 2003. Small sample correction for the variance of GEE estimators. Biom J 45: 395-409. (Pubitemid 36802752)
17. Toovey S, Jamieson A, Holloway M, 2004. Travelers' knowledge, attitudes and practices on the prevention of infectious diseases: results from a study at Johannesburg International Airport. J Travel Med 11: 16-22. (Pubitemid 38198770)
18. Hagmann S, Benavides V, Neugebauer R, Purswani M, 2009. Travel health care for immigrant children visiting friends and relatives abroad: retrospective analysis of a hospital-based travel health service in a US urban underserved area. J Travel Med 16: 407-412.
19. LaRocque R, Rao S, Tsibris A, Lawton T, Barry MA, Marano N, Brunette G, Yanni E, Ryan E, 2010. Pre-travel health adviceseeking behavior among US international travelers departing from Boston Logan International Airport. J Travel Med 17: 387-391.
20. Angell S, Cetron M, 2005. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med 142: 67-72. (Pubitemid 40066215)
21. Bacaner N, Stauffer B, Boulware D, Walker P, Keystone J, 2004. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 291: 2856-2864. (Pubitemid 38747807)
22. Leder K, Chen LH, Wilson ME, 2012. Aggregate travel vs. single trip assessment: arguments for cumulative risk analysis. Vaccine 30: 2600-2604.
23. Anonymous, 2011. WHO: Yellow Fever Reported Cases . Available at: http://apps.who.int/immunization-monitoring/en/globalsummary/timeseries/ tsincidenceyfe.htm. Accessed January 24, 2012.
24. Monath TP, Cetron MS, 2002. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34: 1369-1378. (Pubitemid 34507947)
25. Monath TP, 2012. Review of the risks and benefits of yellow fever vaccination including some new analyses. Expert Rev Vaccines 11: 427-448.
26. WHO, 2008. Update on progress controlling yellow fever in Africa 2004-2008. Wkly Epidemiol Rec 83: 449-460.
27. Schilthuis H, Goossens I, Ligthelm R, de Vlas S, Varkevisser C, Richardus J, 2007. Factors determining use of pre-travel preventive health services by West African immigrants in The Netherlands. Trop Med Int Health 12: 990-998. (Pubitemid 47245822)
28. Hamer D, Connor B, 2004. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med 11: 23-26. (Pubitemid 38198771)
29. FDA, 2012. Biologic Product Shortages. Available at: http://www.fda.gov/ BiologicsBloodVaccines/SafetyAvailability/Shortages/default.htm. Accessed March 28, 2012.